Trulieve Cannabis Corp
OTC:TCNNF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
1.9B CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
978.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.8B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
273B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
96.4B EUR |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Trulieve Cannabis Corp
Glance View
Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. The company is headquartered in Quincy, Florida and currently employs 9,000 full-time employees. The company went IPO on 2018-09-25. The firm is a multi-state operator in the United States operating in states, with market positions in Arizona, Florida, and Pennsylvania. The company is providing products across its brand portfolio and delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. The company operates in regulated markets that require knowledge in cultivation, manufacturing, retail and logistics. The firm utilizes critical ethanol extraction to obtain the cannabis oil used in its products. The company also utilizes carbon dioxide (CO2) extraction for terpene extraction as well as a line of CO2 vaporizer cartridges. The firm has developed a suite of products with stock keeping units (SKUs), including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Trulieve Cannabis Corp is 7.9%, which is above its 3-year median of 6.6%.
Over the last 3 years, Trulieve Cannabis Corp’s Operating Margin has increased from 6.5% to 7.9%. During this period, it reached a low of 4.7% on Sep 30, 2023 and a high of 9.6% on Jun 30, 2024.